FDA approves new nail fungus treatment

June 12, 2014
FDA approves new nail fungus treatment

(HealthDay)—A new topical nail fungus treatment, Jublia, has been approved by the U.S. Food and Drug Administration.

Jublia (efinaconazole) is made by the Canadian company Valeant Pharmaceuticals International Inc., the Associated Press reported Wednesday.

Jublia comes in liquid form and is applied directly to the nail. According to Valeant, FDA approval was based on two studies involving more than 1,600 people with onychomycosis. The findings were published last year in the Journal of the American Academy of Dermatology. Cure rates were about 18 percent for the patients involved in one study, and about 15 percent for those involved in the other.

In a statement, Valeant said it plans to begin marketing Jublia late in 2014.

Explore further: Topical treatment effective for toenail fungal infection

More information: Health Highlights: June 11, 2014

Related Stories

Valeant raises cash-stock offer for Allergan (Update)

May 28, 2014

Valeant Pharmaceuticals has pumped more cash into its bid for Botox maker Allergan, and it also defended its business model on Wednesday, a day after its reluctant acquisition target aired more concerns about a deal.

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

carllvsports
not rated yet Aug 09, 2014
Very interesting! I hope this approach can be rolled out into market as soon as possible, and then I'll give it a shot. I have tried tons of ways to deal with this infection, but none of them seemed really effective for me. Vinegar, tea oil, oral medications can only ease the symptoms, but was never able to kill the bacteria. I'm considering taking a laser treatment, but I'm not sure about the real effect. I got some information from here: http://lasernail therapy.com. Is there anyone who had this kind of treatment before? Thanks for advice.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.